MYND Therapeutics is a digital health company that develops and distributes digital therapies designed to prevent, treat and manage mental, physical and behavioural conditions for people with obesity and eating disorders. MYND’s digital therapies are not about weight loss nor weight gain. Obesity and eating disorders are chronic, progressive, complex and costly diseases that require safe, effective and affordable solutions. Weight loss is one of the results of treating obesity. MYND’s novel solutions are based on years of neuroscience and behavioural science and proven clinical practice tested with thousands and thousands of patients. The company uses immersive technologies like Virtual Reality, Augmented Reality, Extended Reality, A.I., interactive arts, gamification, social support and real data to develop personalized therapies at scale. Worldwide obesity has tripled since 1975. Today, more than 2.1 billion adults, 18 years or older, are overweight. Of these, more than 650 million have obesity. The U.S. rate of obesity stands at 41.9%. Obesity is a global epidemic. The problem with obesity is that there are too many people who don’t know what to do to prevent, treat or manage the chronic condition and too few doctors and therapists to treat it right. Thousands of obesity experts and therapists need training in best clinical practices and need to scale if they want to stay productive and competitive. And that’s the BIG market opportunity we’re addressing.